Benchmark dose for cadmium-induced osteoporosis in women

Toxicology Letters

Volumn 197, Issue 2, 2010, Pages 123-127

  Suwazono, Yasushi ^a,b   Sand, Salomon ^a   Vahter, Marie ^a   Skerfving, Staffan ^c   Lidfeldt, Jonas ^d   Åkesson, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHIBA UNIVERSITY   (Japan)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Benchmark dose; Bone effect; Continuous data; Environmental exposure; Human; Osteoporosis; Risk assessment; Urinary cadmium

Indexed keywords

CADMIUM;

ADULT; ARTICLE; BONE DENSITY; CREATININE URINE LEVEL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LONG TERM EXPOSURE; OSTEOPOROSIS; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SWEDEN; URINALYSIS; WRIST;

BONE DENSITY; CADMIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SWEDEN;

EID: 77953962452     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.05.008     Document Type: Article

References (49)

1. Åkesson A., Lundh T., Vahter M., Bjellerup P., Lidfeldt J., Nerbrand C., Samsioe G., Strömberg U., Skerfving S. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect. 2005, 113:1627-1631.
2. Åkesson A., Bjellerup P., Lundh T., Lidfeldt J., Nerbrand C., Samsioe G., Skerfving S., Vahter M. Cadmium-induced effects on bone in a population-based study of women. Environ. Health Perspect. 2006, 114:830-834.
3. Alfvén T., Elinder C.G., Carlsson M.D., Grubb A., Hellström L., Persson B., Pettersson C., Spång G., Schütz A., Järup L. Low-level cadmium exposure and osteoporosis. J. Bone Miner. Res. 2000, 15:1579-1586.
4. Alfvén T., Elinder C.G., Hellström L., Lagarde F., Järup L. Cadmium exposure and distal forearm fractures. J. Bone Miner. Res. 2004, 19:900-905.
5. Amzal B., Julin B., Vahter M., Wolk A., Johanson G., Åkesson A. Population toxicokinetic modeling of cadmium for health risk assessment. Environ. Health Perspect. 2009, 117:1293-1301.
6. Barany E., Bergdahl I.A., Schutz A., Skerfving S., Oskarsson A. Inductively coupled plasma mass spectrometry for direct multi-element analysis of diluted human blood and serum. J. Anal. At. Spectrom. 1997, 12:1005-1009.
7. Barregard L., Fabricius-Lagging E., Lundh T., Molne J., Wallin M., Olausson M., Modigh C., Sallsten G. Cadmium, mercury, and lead in kidney cortex of living kidney donors: Impact of different exposure sources. Environ. Res. 2010, 110:47-54.
8. Bhattacharyya M.H. Cadmium osteotoxicity in experimental animals: mechanisms and relationship to human exposures. Toxicol. Appl. Pharmacol. 2009, 238:258-265.
9. Budtz-Jørgensen E., Grandjean P., Keiding N., White R.F., Weihe P. Benchmark dose calculations of methylmercury-associated neurobehavioral deficits. Toxicol. Lett. 2000, 112-113:193-199.
10. Crump K.S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984, 4:854-871.
11. Crump K. Calculation of benchmark doses from continuous data. Risk Anal. 1995, 15:79-89.
12. Crump K. Critical issues in benchmark calculations from continuous data. Crit. Rev. Toxicol. 2002, 32:133-153.
13. Crump K.S., Van Landingham C., Shamlaye C., Cox C., Davidson P.W., Myers G.J., Clarkson T.W. Benchmark concentrations for methylmercury obtained from the Seychelles Child Development Study. Environ. Health Perspect. 2000, 108:257-263.
14. EFSA Scientific opinion of the panel on contaminants in the food chain on a request from the European Commission on cadmium in food. EFSA J, 2009, 980:1-139. (http://www.efsa.europa.eu/en/scdocs/doc/contam_op_ej980_cadmium_en_rev.1,2.pdf, May 12, 2010).
15. FAO/WHO (Food and Agriculture Organization/World Health Organization), 1988. Evaluation of certain food additives and contaminants (Thirty-third report of the Joint FAO/WHO Expert Committee on Food Additives). WHO Technical Report Series, No. 776. World Health Organization, Geneva.
16. Filipsson A.F., Sand S., Nilsson J., Victorin K. The benchmark dose method--review of available models, and recommendations for application in health risk assessment. Crit. Rev. Toxicol. 2003, 33:505-542.
17. Friberg L., Vahter M. Assessment of exposure to lead and cadmium through biological monitoring: results of a UNEP/WHO global study. Environ. Res. 1983, 30:95-128.
18. Gallagher C.M., Kovach J.S., Meliker J.R. Urinary cadmium and osteoporosis in U.S. Women >or= 50 years of age: NHANES 1988-1994 and 1999-2004. Environ. Health Perspect. 2008, 116:1338-1343.
19. Gallagher C.M., Moonga B.S., Kovach J.S. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III. Environ. Res. 2010, 110:105-111.
20. Gaylor D.W., Slikker W. Risk assessment for neurotoxic effects. Neurotoxicology 1990, 11:211-218.
21. Honda R., Tsuritani I., Noborisaka Y., Suzuki H., Ishizaki M., Yamada Y. Urinary cadmium excretion is correlated with calcaneal bone mass in Japanese women living in an urban area. Environ. Res. 2003, 91:63-70.
22. Hong F., Jin T., Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. BioMetals 2004, 17:573-580.
23. Järup L., Åkesson A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238:201-208.
24. Jin T., Wu X., Tang Y., Nordberg M., Bernard A., Ye T., Kong Q., Lundstrom N.-G., Nordberg G.F. Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China. BioMetals 2004, 17:525-530.
25. Kanis J.A., Delmas P., Burckhardt P., Cooper C., Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos. Int. 1997, 7:390-406.
26. Kobayashi E., Suwazono Y., Uetani M., Inaba T., Oishi M., Kido T., Nishijo M., Nakagawa H., Nogawa K. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan. J. Appl. Toxicol. 2006, 26:351-355.
27. Kobayashi E., Suwazono Y., Uetani M., Kido T., Nishijo M., Nakagawa H., Nogawa K. Tolerable level of lifetime cadmium intake estimated as a benchmark dose low, based on excretion of beta2-microglobulin in the cadmium-polluted regions of the Kakehashi River Basin, Japan. Bull. Environ. Contam. Toxicol. 2006, 76:8-15.
28. Kobayashi E., Suwazono Y., Dochi M., Honda R., Nishijo M., Kido T., Nakagawa H. Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan. Toxicol. Lett. 2008, 179:108-112.
29. Kobayashi E., Suwazono Y., Dochi M., Honda R., Kido T. Association of lifetime cadmium intake or drinking Jinzu River water with the occurrence of renal tubular dysfunction. Environ. Toxicol. 2009, 24:421-428.
30. Kobayashi E., Suwazono Y., Dochi M., Honda R., Kido T. Estimation of benchmark rice cadmium doses as threshold values for abnormal urinary findings with adjustment for consumption of Jinzu River water. Bull. Environ. Contam. Toxicol. 2009, 83:102-107.
31. Lidfeldt J., Nerbrand C., Samsioe G., Schersten B., Agardh C.D. A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population-based study of middle-aged Swedish women. Eur. J. Epidemiol. 2001, 17:943-951.
32. Murata K., Budtz-Jørgensen E., Grandjean P. Benchmark dose calculations for methylmercury-associated delays on evoked potential latencies in two cohorts of children. Risk Anal. 2002, 22:465-474.
33. Murata K., Weihe P., Budtz-Jørgensen E., Jørgensen P.J., Grandjean P. Delayed brainstem auditory evoked potential latencies in 14-year-old children exposed to methylmercury. J. Pediatr. 2004, 144:177-183.
34. National Research Council, 2001. Arsenic in Drinking Water: 2001 Update. National Academy Press, Washington, D.C.
35. Nawrot T., Geusens P., Nulens T., Nemery B. Occupational cadmium exposure and calcium excretion, bone density and osteoporosis in men. J. Bone Miner. Res. 2010, 25:1441-1445.
36. Nordberg G.F., Nogawa K., Nordberg M., Friberg L.T., Gunnar F.N., Bruce A.F., Monica N., Lars T.F. Cadmium. Handbook on the Toxicology of Metals 2007, Academic Press, Burlington, 445-486. Third Edition.
37. Orlowski C., Piotrowski J.K., Subdys J.K., Gross A. Urinary cadmium as indicator of renal cadmium in humans: an autopsy study. Hum. Exp. Toxicol. 1998, 17:302-306.
38. Royston P., Sauerbrei W., Altman D.G. Modeling the effects of continuous risk factors. J. Clin. Epidemiol. 2000, 53:219-221.
39. Sand S., von Rosen D., Eriksson P., Fredriksson A., Viberg H., Victorin K., Filipsson A.F. Dose-response modeling and benchmark calculations from spontaneous behavior data on mice neonatally exposed to 2,2',4,4',5-pentabromodiphenyl ether. Toxicol. Sci. 2004, 81:491-501.
40. Schutte R., Nawrot T.S., Richart T., Thijs L., Vanderschueren D., Kuznetsova T., Van Hecke E., Roels H.A., Staessen J.A. Bone resorption and environmental exposure to cadmium in women: a population study. Environ. Health Perspect. 2008, 116:777-783.
41. Shimizu A., Kobayashi E., Suwazono Y., Uetani M., Oishi M., Inaba T., Kido T., Nogawa K. Estimation of benchmark doses for urinary cadmium based on beta2-microglobulin excretion in cadmium-polluted regions of the Kakehashi River basin, Japan. Int. J. Environ. Health Res. 2006, 16:329-337.
42. Staessen J.A., Roels H.A., Emelianov D., Kuznetsova T., Thijs L., Vangronsveld J., Fagard R. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet 1999, 353:1140-1144.
43. Suwazono Y., Sand S., Vahter M., Filipsson A.F., Skerfving S., Lidfeldt J., Akesson A. Benchmark dose for cadmium-induced renal effects in humans. Environ. Health Perspect. 2006, 114:1072-1076.
44. Suwazono Y., Kido T., Nakagawa H., Nishijo M., Honda R., Kobayashi E., Dochi M., Nogawa K. Biological half-life of cadmium in the urine of inhabitants after cessation of cadmium exposure. Biomarkers 2009, 14:77-81.
45. Uno T., Kobayashi E., Suwazono Y., Okubo Y., Miura K., Sakata K., Okayama A., Ueshima H., Nakagawa H., Nogawa K. Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium. Scand. J. Work Environ. Health. 2005, 31:307-315.
46. U.S. Department of Health and Human Services, 2004. Bone Health and Osteoporosis: A Report of the Surgeon General. U.S. Department of Health and Human Services, Office of the Surgeon General, Rockville, MD.
47. U.S. EPA, 1995. The Use of the Benchmark Dose (BMD) Approach in Health Risk Assessment. Final report. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC.
48. West R.W., Kodell R.L. A comparison of methods of benchmark dose estimation for continuous response data. Risk Anal. 1999, 19:453-459.
49. WHO, 1994. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO, Geneva.